Sun Pharma Global Fze recalls
Sun Pharma Global Fze has 4 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 9 Mar 2016. The most frequent reason is potency & assay.
Total recalls4since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 9 Mar 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 75%Class III 1 25%
Why sun pharma global fze is recalled
Product types
By year
All sun pharma global fze recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Alendronate Sodium Tablets, USP, 70 mg* blisters recalled | Sun Pharma Global Fze | Potency & Assay | Nationwide |
| Drug | CLASS III | buPROPion Hydrochloride Extended-¿release Tablets USP (SR) recalledBupropion Hydrochloride | Sun Pharma Global Fze | Potency & Assay | Nationwide |
| Drug | CLASS II | Ketorolac Tromethamine Ophthalmic Solution recalled | Sun Pharma Global Fze | Particulate Matter | Nationwide |
| Drug | CLASS II | Levetiracetam, extended release tablets, 750 mg recalled | Sun Pharma Global Fze | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.